Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-11-000715
Filing Date
2011-02-14
Accepted
2011-02-14 13:50:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC FILING sec_filing.htm SC 13G/A 17810
  Complete submission text file 0000902219-11-000715.txt   19881
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 11605176
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 CONGRESS STREET BOSTON MA 02210
Business Address 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000